A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...
Sinocare announced recently that it successfully defended itself in court against trademark infringement claims brought by ...
We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...
On January 22, Abbott Laboratories published financial ... an over-the-counter continuous glucose monitoring system, in early September 2024. Secondly, sales of its structural heart products ...
Strong growth in the Libre CGM segment, with sales surpassing $1.6 billion. Abbott is targeting high single-digit top-line growth in 2025. Abbott Laboratories demonstrated solid performance in Q3 ...
Abbott Laboratories’ ABT growth in the fourth quarter ... the company is driving robust growth through its flagship, sensor-based CGM system — FreeStyle Libre. However, a dull macroeconomic ...
The FreeStyle Libre 3 system helped Nathan manage his diabetes. Now, he's sharing his story to help lift stigma.Abbott NORTHAMPTON, MA / ACCESS Newswire / February 7, 2025 / As a competitive powerlift ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback